Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Mc001
1. Schembl25799841
2. Glxc-25431
3. Mc001
4. Mc-001
| Molecular Weight | 236.4 g/mol |
|---|---|
| Molecular Formula | C6H16N6S2 |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 179 |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 200 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
44
PharmaCompass offers a list of N-Cystaminyl Biguanide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right N-Cystaminyl Biguanide manufacturer or N-Cystaminyl Biguanide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred N-Cystaminyl Biguanide manufacturer or N-Cystaminyl Biguanide supplier.
A N-Cystaminyl Biguanide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of N-Cystaminyl Biguanide, including repackagers and relabelers. The FDA regulates N-Cystaminyl Biguanide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. N-Cystaminyl Biguanide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A N-Cystaminyl Biguanide supplier is an individual or a company that provides N-Cystaminyl Biguanide active pharmaceutical ingredient (API) or N-Cystaminyl Biguanide finished formulations upon request. The N-Cystaminyl Biguanide suppliers may include N-Cystaminyl Biguanide API manufacturers, exporters, distributors and traders.
N-Cystaminyl Biguanide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of N-Cystaminyl Biguanide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right N-Cystaminyl Biguanide GMP manufacturer or N-Cystaminyl Biguanide GMP API supplier for your needs.
A N-Cystaminyl Biguanide CoA (Certificate of Analysis) is a formal document that attests to N-Cystaminyl Biguanide's compliance with N-Cystaminyl Biguanide specifications and serves as a tool for batch-level quality control.
N-Cystaminyl Biguanide CoA mostly includes findings from lab analyses of a specific batch. For each N-Cystaminyl Biguanide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
N-Cystaminyl Biguanide may be tested according to a variety of international standards, such as European Pharmacopoeia (N-Cystaminyl Biguanide EP), N-Cystaminyl Biguanide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (N-Cystaminyl Biguanide USP).
